Crawford’s First Business After Confirmation: Brief Senators On Mifeprex
Executive Summary
FDA Commissioner Lester Crawford's first business following his confirmation was to brief members of Congress about reports of deaths in patients using Danco Laboratories' abortifacientMifeprex